Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS)

97 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q3 2019.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,070,550 shares of 108,380,780 outstanding shares and own 27% of the company stock.
Largest 10 shareholders include Man Group plc (3,734,793 shares), BlackRock Inc. (3,031,068 shares), Rock Springs Capital Management LP (2,974,754 shares), RENAISSANCE TECHNOLOGIES LLC (1,968,716 shares), Sofinnova Investments, Inc. (1,911,573 shares), Endurant Capital Management LP (1,769,785 shares), MORGAN STANLEY (1,728,041 shares), Broadfin Capital, LLC (1,620,000 shares), MFN Partners Management, LP (1,500,000 shares), and VANGUARD GROUP INC (1,375,843 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.